Description

Links to resources mentioned in this episode: 

• Low Dose of Hydroxychloroquine Reduces Fatality of Critically Ill Patients With COVID-19 (PubMed)
• Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19 (New England Journal of Medicine)
• Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis (The Lancet)
• The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro (Science Direct)
• Usefulness of Ivermectin in COVID-19 Illness (SSRN)
• Remdesivir for the Treatment of Covid-19 — Preliminary Report (New England Journal of Medicine)